Selected article for: "subsequent fusion and virus subsequent fusion"
Author: Chen, Zhaoyu; Cui, Qinghua; Caffrey, Michael; Rong, Lijun; Du, Ruikun
Title: Small Molecule Inhibitors of Influenza Virus Entry
  • Cord-id: ot8m4rxi
  • Document date: 2021_6_18
    • ID: ot8m4rxi
    Snippet: Hemagglutinin (HA) plays a critical role during influenza virus receptor binding and subsequent membrane fusion process, thus HA has become a promising drug target. For the past several decades, we and other researchers have discovered a series of HA inhibitors mainly targeting its fusion machinery. In this review, we summarize the advances in HA-targeted development of small molecule inhibitors. Moreover, we discuss the structural basis and mode of action of these inhibitors, and speculate upon
    Document: Hemagglutinin (HA) plays a critical role during influenza virus receptor binding and subsequent membrane fusion process, thus HA has become a promising drug target. For the past several decades, we and other researchers have discovered a series of HA inhibitors mainly targeting its fusion machinery. In this review, we summarize the advances in HA-targeted development of small molecule inhibitors. Moreover, we discuss the structural basis and mode of action of these inhibitors, and speculate upon future directions toward more potent inhibitors of membrane fusion and potential anti-influenza drugs.

    Search related documents:
    Co phrase search for related documents
    • action mechanism and low toxicity: 1, 2, 3, 4, 5, 6, 7
    • action mechanism and luciferase assay: 1, 2, 3, 4
    • action mechanism moa and acute respiratory syndrome coronavirus: 1
    • action mechanism moa and low toxicity: 1
    • action mode and acute respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41
    • action mode and low micromolar potency: 1, 2
    • action mode and low toxicity: 1, 2, 3, 4
    • action mode and luciferase assay: 1, 2
    • action site and acute respiratory syndrome coronavirus: 1, 2, 3
    • acute respiratory syndrome coronavirus and low micromolar potency: 1, 2, 3
    • acute respiratory syndrome coronavirus and low toxicity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • acute respiratory syndrome coronavirus and luciferase assay: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17